Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global transplantation market size reached a value of USD 15.10 billion in 2023. The market is likely to grow at a rate of 9.4% in the forecast period of 2024-2032 to reach a market value of USD 33.89 billion by 2032. The increasing research and developmental activities, along with technological advancements are supporting the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Transplantation is one of the most advanced and great advances in modern medicine. Transplantation is a procedure of removing organ, tissue, or cells from one subject and surgically placing it in another subject whose organ has failed. The former is called the donor, while the latter is referred to as a recipient. Transplantation is generally considered the last therapeutic intervention in cases of organ failure or damage due to any disease or injury.
The organs that can be donated include the heart, kidneys, pancreas, uterus, liver, lungs, and intestine. The tissues being transplanted from the healthy donor to the recipient are the bones, heart valves, skin patches, tendons, cornea, and nerves. Out of the tissues, cornea and musculoskeletal grafts are majorly transplanted, while kidneys are the most transplanted organs in the human body.
There are several types of transplants, including autograft, allograft, domino transplants, xenograft, and ABO-incompatible transplants. The organs or tissues can be donated from either a living or deceased donor. There has been the formulation of several laws and regulations in both developed and developing countries for enhancing the safety and availability of organ or tissue transplants to their citizens.
The transplantation market can be categorised into the following segments:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Type of Transplant
Transplantation Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growth of the transplantation market is driven by the rising cases of organ failure, which can be attributed to the growing incidence of acute and chronic diseases, including poisoning, trauma, leukaemia, and sepsis. This has led to increased demand for tissue and organ transplants and thus will facilitate market growth and development.
The emergence of unhealthy eating habits, increased consumption of alcohol, drug abuse and lack of physical exercise are also increasing the chances of organ failure. This is anticipated to accelerate the demand for organ or tissue transplants and will directly influence the growth of the transplantation market during the forecast period.
Tissue products are expected to hold a significant share in the market owing to the increasing number of transplantation procedures incorporating the application of tissue products, such as orthopaedic soft tissues, heart valves, and bone marrow. This is expected to attribute to the major share of this segment. The growing number of product launches and approvals and the rising number of mergers and acquisitions are also projected to fuel the market development.
North America is anticipated to dominate the transplantation market due to the well-developed healthcare facilities and the strategic presence of major pharmaceutical companies, like Arthrex, Zimmer Biomet, Stryker, Novartis, and Medtronic in the region. Further, the increasing initiatives by the government and other non-governmental organisations to aware people of organ donations are also expected to accelerate the market in the forthcoming years.
Transplantation is a wide branch of modern medicine and is used for the treatment of several therapeutic indications. Tremendous efforts of scientists, researchers, and healthcare professionals have led to innovative transplantation methods that have helped to improve healthcare and the global economy.
One of the emerging therapies incorporating transplantation is cell transplantation or cell therapy. The therapeutic interventions include hematopoietic stem cell transplantation, neural stem cell therapy, and mesenchymal stem cell therapy. These therapies are utilized in the cases of myeloid malignancies, osteogenesis imperfecta, Hurler’s syndrome, and other haematological indications.
The transplantation of the entire bladder or the bladder tissue from a healthy donor to the recipient has also provided therapeutic effects in the management of renal disorders. The bladders are biosynthesized which can be then transplanted into the patient’s body. Kidney and liver transplants are being utilized in case of renal dysfunction and hepatic failure.
A heart transplant is used in patients suffering from congestive heart failure, for restoring the normal functioning of the heart. Other organ transplants including lung transplants are also used in the treatment of pulmonary disorders, wherein, one or both lungs have stopped functioning and the patient is expected to survive for less than two years.
Stem cell transplant is another transplantation technique which is applied for the management of the disease damaging the bone marrow cells. This type of transplant gives rise to novel blood cells, thus replacing the damaged cells in the body.
With extensive research and innovations, clinical researchers are working on discovering novel organ/tissue transplantations that would be useful in the treatment of novel therapeutic indications. The undergoing clinical trials are expected to utilize novel technologies and methods, that are more efficient therapeutically.
In the United States, LyGenesis, a key market player is performing clinical trials for the novel technique, involves the development of ectopic livers. In this intervention, the cells are injected from the donor liver which is expected to form multiple mini livers thus, expected to keep the patient healthy. If successfully passed, this can be used for the management of patients suffering from end-stage liver disease.
A novel method of islet transplantation is under stage III clinical trials for testing the degree and effect of insulin independence in patients suffering from diabetes. In this method, the normal islet cells from the healthy donor are injected into the patient, which aids in the production of insulin and thus controls diabetes.
Paragonix technologies, a major market leader, has launched a novel organ tracking technology to make the entire in-transit of donor organs transparent. This will be used to capture the exact location of the device and thus, will help in early transportation and will increase the chances of saving the patient life.
The positive results of these trials, the invention of novel methods, better advancements and increased understanding and awareness will also propel the market expansion in the near future.
The report gives an in-depth analysis of the key players involved in the market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The transplantation market companies included in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Category of Product |
|
Breakup by Type of Transplant |
|
Breakup by Application |
|
Breakup by End-User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
The market size is likely to reach a value of USD 15.10 billion in 2023.
The market is likely to grow at a CAGR of 9.4% during the forecast period of 2024-2032 to attain a value of USD 33.89 billion by 2032.
Based on the product, the market is segmented into transplant preservative solutions, transplant diagnostics, tissue products, and immunosuppressive drugs, among others.
Based on the transplant type, the market is categorised into solid organ transplant, tissue transplant, and stem cell transplant.
Based on the application, the market is segmented into clinical therapeutics, translational research, and diagnostic purposes, among others.
Based on the end user, the market is categorised into hospitals and transplantation centres, among others.
The different regions in the market are North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The key companies in the market are AbbVie Inc., Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, 21st Century Medicine, BioLife Solutions, Teva Pharmaceutical Industries Ltd., and Astellas Pharma Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124